Omnibus Act VIII – Further upcoming restrictions
The European Union is introducing significant changes to cosmetic ingredient regulations under Omnibus Act VIII, which will take effect on May 1, 2026. The above Act expands the list of substances classified as Carcinogenic, Mutagenic, or Toxic for Reproduction (CMRs) that are either banned or subject to strict restrictions in cosmetic products. All non-compliant cosmetic products must […]
U.S. FDA Withdraws Proposed Testing Rule for Talc-Containing Cosmetics
End of last year, the U.S. Food and Drug Administration (FDA) issued an unpublished notice titled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal,” formally withdrawing its previously proposed rule on this topic. The withdrawal took effect upon the issuance of the notice. Under the now-withdrawn proposal, FDA had considered establishing specific […]
FDA Proposes Adding Bemotrizinol to the List of Permitted Sunscreen Active Ingredients
The U.S. Food and Drug Administration (FDA) has issued a proposed order that would add bemotrizinol to the list of permitted sunscreen active ingredients. According to the FDA: – bemotrizinol provides broad-spectrum UV protection and demonstrates low systemic absorption. – Bemotrizinol has a low irritation potential– if the proposed order is finalized, it would be […]
Thailand Simplifies Notification Process for Low-Risk Cosmetics
On December 2, 2025, the Thai Food and Drug Administration (Thai FDA) published a new guidance document titled “Steps for Notifying Low-Risk Cosmetic Products.” The document aims to support manufacturers and importers in the notification process required for low-risk cosmetics in Thailand. Under Thai FDA definitions, low-risk cosmetics are products considered unlikely to cause harm […]
EU Regulatory update for tea tree oil
After several years of debate regarding the safety of tea tree oil (TTO) in cosmetic products, the EU’s Scientific Committee on Consumer Safety (SCCS) published its final opinion on 14 November 2025. The SCCS concluded that TTO can be considered safe as an anti-seborrhoeic and anti-microbial ingredient in four specific product categories, subject to strict […]
Indonesia Issues Draft Decree on new Halal Requirements
On November 17, 2025, Indonesia’s Halal Product Assurance Organizing Agency (BPJPH) notified the World Trade Organization (WTO) of a draft Decree on Guidelines for Implementing the Halal Product Assurance System in Storage, Packaging, and Distribution Services. The draft establishes that logistics services linked to cosmetics, food, pharmaceuticals, and other regulated products are subject to halal certification, reflecting […]
Argentina Introduces New Authorization System for Cosmetic Establishments
On October 27, Argentina’s National Administration of Drugs, Food and Medical Devices (ANMAT) issued Order No. 7939/2025, updating requirements for the authorization of business activities related to the manufacture, import, and distribution of cosmetics, personal hygiene products, and perfumes (collectively referred as cosmetic products). This new regulation will repeal existing frameworks and is part of […]
Spain Introduces Draft on Accessible Labelling for Consumer Products
Just before Christmas, the Spanish Government formally requested the European Commission, via the TRIS system, to withdraw the draft Royal Decree on accessible labelling of consumer products. The request concerns the measure notified under Directive (EU) 2015/1535, reference 2025/0311/ES. Background to the Withdrawal» The draft Royal Decree was notified to the Commission and EU Member […]
China Selects First Batch of New Cosmetic Ingredients for Innovation Guidance
In October, the China National Institutes for Food and Drug Control (NIFDC) released the first batch of new cosmetic ingredients (NCIs) selected under its innovation guidance program. This initiative marks a key step in China’s strategy to encourage innovation and self-reliance in the cosmetics sector by promoting the research, development, and application of novel ingredients. […]
India Introduces Draft Medicines, Medical Devices and Cosmetics Act
India is preparing a new Drugs, Medical Devices and Cosmetics Act, aimed at strengthening quality control, market surveillance, and regulatory modernization across the country’s healthcare and cosmetics sectors. The draft Act was officially presented on October 14, 2025, and is expected to be formally presented during the Winter Session of Parliament in December for discussion […]
